Gut Hormone Cells Keep Your Intestinal Barrier Intact — And Their Peptides Could Treat Leaky Gut | Research

The takeaway

Hormone-producing cells in the gut are essential for maintaining intestinal barrier integrity, and the peptides PYY and octreotide can directly repair barrier defects even during inflammation.

Zero barrier therapies exist
There are currently no drugs that directly improve intestinal barrier permeability — this study shows gut peptides PYY and octreotide could be the first

What the researchers found

Enteroendocrine cells — hormone-producing cells in the gut lining — are required to maintain a healthy intestinal barrier. When human intestinal organoids were genetically engineered to lack these cells, barrier function deteriorated in both stem cell-like and mature tissue. Adding the peptide hormones PYY (peptide tyrosine-tyrosine) and octreotide (a somatostatin analog) rescued barrier function both at baseline and in the presence of the inflammatory cytokine TNF. Surprisingly, the barrier improvement occurred without significant changes in tight junction protein levels, suggesting a novel mechanism.

Why it matters

There are currently no drugs that directly strengthen the intestinal barrier — a central problem in inflammatory bowel disease, where a leaky gut drives a cycle of worsening inflammation. This study reveals that gut hormones PYY and somatostatin can directly improve barrier integrity, opening an entirely new therapeutic avenue for IBD and other conditions involving intestinal permeability.

The numbers in context

PYY and octreotide rescued barrier defects · Barrier improvement occurred independently of tight junction protein (ZO-1, occludin, claudin-2) changes · Effective both at baseline and under TNF-induced inflammation

How the study worked

Researchers grew human intestinal enteroids (miniature gut tissue models) on Transwell filters. They used genetic knockout to remove enteroendocrine cells and measured barrier function via transepithelial electrical resistance and paracellular permeability assays. They then supplemented the EEC-deficient cultures with PYY and octreotide to test whether these hormones could restore barrier function. Tight junction proteins were assessed by immunostaining and abundance measurements.

Who was studied

Human intestinal enteroids (organoid model system)

What this study cannot tell us

This is an in-vitro study using human intestinal organoids, not living patients. While organoids are more representative than cell lines, they lack the immune cells, blood vessels, and microbiome present in a real gut. The study did not test other enteroendocrine hormones (like GLP-1 or GLP-2) that might also contribute. Dosing and timing that would be effective in human IBD patients are unknown.

How to read the evidence

This is an in-vitro study using a well-validated human intestinal organoid model, published in the American Journal of Physiology. The genetic knockout approach provides strong mechanistic evidence, but the findings need validation in animal models and human patients.

When this study was published

Published in 2025, this is very recent research presenting a novel therapeutic concept for intestinal barrier repair that has not yet been tested clinically.

The bigger picture

Leaky gut is a central driver of inflammatory bowel disease and may play a role in many other conditions. Despite this, no current therapy directly targets intestinal barrier permeability. This study identifies gut peptide hormones as a previously unknown barrier-strengthening mechanism, potentially opening a new drug class. Notably, octreotide is already FDA-approved for other conditions, which could accelerate clinical testing for barrier repair.

Questions still open

Would PYY or octreotide improve intestinal barrier function in living IBD patients, not just in organoid models?
Do other enteroendocrine hormones like GLP-1 or GLP-2 also contribute to barrier maintenance?
What is the molecular mechanism by which these peptides strengthen the barrier without changing tight junction protein levels?

Common questions

What are enteroendocrine cells and why do they matter for gut health?

Enteroendocrine cells are hormone-producing cells scattered throughout your gut lining. They're best known for releasing hormones like PYY, GLP-1, and somatostatin that control digestion and appetite. This study revealed they also play a critical role in keeping the intestinal barrier sealed, which is essential for preventing bacteria and toxins from leaking through the gut wall.

Could this lead to a treatment for inflammatory bowel disease?

Potentially. The study shows that gut peptides PYY and octreotide can directly repair intestinal barrier defects, even in the presence of inflammation. Since a leaky barrier drives the worsening cycle of IBD, a drug that seals the barrier could be a game-changer. Octreotide is already FDA-approved for other uses, which could accelerate clinical testing.

Read the original research

Enteroendocrine cells regulate intestinal barrier permeability.

American journal of physiology. Cell physiology, 328(5), C1501-C1508

View on PubMed ↗Publisher’s paper ↗

Citation

Nwako, Jennifer G; Patel, Sparsh D; Roach, Taevon J; Gupte, Saanvi R; Williams, Samara G; Riedman, Anne Marie; McCauley, Heather A. (2025). Enteroendocrine cells regulate intestinal barrier permeability.. American journal of physiology. Cell physiology, 328(5), C1501-C1508. https://doi.org/10.1152/ajpcell.01077.2024